DexCom, Inc. (ETR:DC4)

Market Cap	23.98B -21.4%
Revenue (ttm)	3.85B +14.2%
Net Income	614.25M +5.9%
EPS	1.53 +7.8%
Shares Out	n/a
PE Ratio	39.03
Forward PE	29.85
Dividend	n/a
Ex-Dividend Date	n/a

Volume	94
Average Volume	444
Open	61.10
Previous Close	60.94
Day's Range	61.10 - 62.14
52-Week Range	47.00 - 88.54
Beta	n/a
RSI	60.84
Earnings Date	Feb 12, 2026

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 10,300
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: DC4

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD